Patent ID: 11946054
Assignee: PRECIGEN, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  G | IPC C  G

Claim 27:
28. The method of claim 24, wherein the chimeric antigen receptor comprises:
(a) an amino acid sequence having at least 90% identity with SEQ ID NO: 218 and an amino acid sequence having at least 90% identity with SEQ ID NO: 219;
(b) an amino acid sequence having at least 90% identity with SEQ ID NO: 220 and an amino acid sequence having at least 90% identity with SEQ ID NO: 221;
(c) an amino acid sequence having at least 90% identity with SEQ ID NO: 222 and an amino acid sequence having at least 90% identity with SEQ ID NO: 223;
(d) an amino acid sequence having at least 90% identity with SEQ ID NO: 224 and an amino acid sequence having at least 90% identity with SEQ ID NO: 225; or
(e) an amino acid sequence having at least 90% identity with SEQ ID NO: 226 and an amino acid sequence having at least 90% identity with SEQ ID NO: 227.